CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/15081416

Biochem. Biophys. Res. Commun. 2004 May 7 317 3 837-43

Download in:

View as

General Info

PMID
15081416